ABSTRACT Pituitary adenomas comprise approximately 10-20% of intracranial tumors. Non-
functioning pituitary adenomas (NFPAs) are benign adenohypophyseal tumors not …

Purpose Non-functioning pituitary adenomas (NFPAs) are associated with impaired well-
being, increased comorbidities, and reduced long-term survival. Data on optimal …

Surgical removal of non-functioning pituitary adenoma (NFPA) is the first-choice therapeutic
option, but radical removal of the tumor cannot be accomplished in all patients. The best …

Objective The long-term outcome of non-functioning pituitary adenoma (NFPA) patients is
not clearly established, probably due to the low annual incidence and prolonged natural …

Purpose Non-functioning pituitary adenomas (NFPAs) are benign pituitary neoplasms that
do not cause a hormonal hypersecretory syndrome. An improved understanding of their …

Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that
are not hormonally active. They are not associated with clinical syndromes such as …

Post-surgical surveillance of non-functioning pituitary adenoma (NFPA) is based on
magnetic resonance imaging (MRI) at 3 or 6 months then 1 year. When there is no …

To determine the indications for postoperative radiotherapy after surgical resection of a
nonfunctioning pituitary macroadenoma. A retrospective chart review of 72 patients with …

Objective To assess the clinical outcome of a strategy of conservative monitoring of patients
with nonfunctioning pituitary adenomas (NFPA) after pituitary surgery and in patients without …

In contrast to the clear indication for surgical treatment in symptomatic patients with clinically
nonfunctioning pituitary adenomas (NFPA), there are no randomized controlled studies …